toddacoumalone   Click here for help

GtoPdb Ligand ID: 13467

Synonyms: compound 8 [PMID: 24597921]
Immunopharmacology Ligand
Compound class: Natural product
Comment: Toddacoumalone is one of a number of coumarin type compounds identified in extracts from the roots of the African Zanthoxylum (Toddalia) asiatica climbing plant. The plant is used medicinally by many African peoples. Experimental analysis demonstrates that toddacoumalone inhibits phosphodiesterase 4 (PDE4) enzymatic activity [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 0
Rotatable bonds 5
Topological polar surface area 74.3
Molecular weight 513.58
XLogP 4.15
No. Lipinski's rules broken 1

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(=C[C@@H]1C[C@](C)(/C=C/C2=C(C=C(C3=C2OC(=O)C=C3)OC)OC)OC4=C1C(=O)N(C)C5=C4C=CC=C5)C
Isomeric SMILES COC1=CC(OC)=C(/C=C/[C@@]2(C)C[C@@H](C=C(C)C)C3=C(O2)C4=CC=CC=C4N(C)C3=O)C5=C1C=CC(=O)O5
InChI InChI=1S/C31H31NO6/c1-18(2)15-19-17-31(3,38-29-20-9-7-8-10-23(20)32(4)30(34)27(19)29)14-13-22-25(36-6)16-24(35-5)21-11-12-26(33)37-28(21)22/h7-16,19H,17H2,1-6H3/b14-13+/t19-,31+/m1/s1
InChI Key IOVBMEHJQSKXAU-CSLHTZHMSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Bioactivity Comments
In vitro, toddacoumalone inhibited PDE4D2 catalysis more potently (IC50 140 nM) than the well-characterized PDE4 inhibitor rolipram (IC50 590 nM) [1]
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
phosphodiesterase 4D Hs Inhibitor Inhibition 6.8 pIC50 - 1
pIC50 6.8 (IC50 1.4x10-7 M) [1]
Description: Inhibition of PDE4D2